Jonas Göran Ekblom

President & Chief Executive Officer at Promore Pharma AB

Jonas Göran Ekblom

Jonas Göran Ekblom

President & Chief Executive Officer at Promore Pharma AB

Overview
Career Highlights

Nanostream, Inc.
Pergamum AB
Promore Pharma AB

RelSci Relationships

278

Number of Boards

6

Birthday

1965

Age

55

Contact Data
Trying to get in touch with Jonas Göran Ekblom? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Jonas Göran Ekblom likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Nicklasson Life Science AB

Relationship likelihood: Strong

Managing Director at Midroc New Technology AB

Relationship likelihood: Strong

Chief Executive Officer & Director at Combigene AB

Relationship likelihood: Strong

Vice Chairman at Mobidiag Oy

Relationship likelihood: Strong

Partner at Rosetta Capital Ltd.

Relationship likelihood: Strong

Chief Executive Officer at Scandicure AB

Relationship likelihood: Strong

Associate Professor at University of Uppsala

Relationship likelihood: Strong

Accountant at Södertörns Energi AB

Relationship likelihood: Strong

Former Professional at BRI International, Inc.

Relationship likelihood: Strong

Former Chief Financial Officer & Director at EffRx Pharmaceuticals SA

Relationship likelihood: Strong

Paths to Jonas Göran Ekblom
Potential Connections via
Relationship Science
You
Jonas Göran Ekblom
President & Chief Executive Officer at Promore Pharma AB
Education

Stockholm University is a state university in Stockholm, Sweden. Stockholm University has two scientific fields: the natural sciences and the humanities/social sciences. It has over 66,000 students at four different faculties: law, humanities, the mathematical and natural sciences making it one of the largest universities in Scandinavia. The institution is also frequently regarded as one of the top 200 universities in the world.

Uppsala Universty is a world class research and educational institution in Sweden.

Career History
Chief Executive Officer
2010 - Current

Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden.

President & Chief Executive Officer
2010 - Current

Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. Its projects include PXL01 and LL-37. The PXL01 project will be used for prevention of post-surgical adhesions and scars is being prepared for clinical Phase III-studies in patients undergoing tendon repair surgery in the hand. The LL-37 project will used to prepare for a clinical Phase IIb study in patients with venous leg ulcers. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden.

Associate Professor
Current

Uppsala Universty is a world class research and educational institution in Sweden.

Boards & Committees
Director
Prior - 2012

Anaborex, Inc. provides clinical research services for metabolic diseases. The company develops drugs for the treatment of cancer related wasting syndrome. It was founded in 2005 by Alan Saven and Jorge Nieva and is located in La Jolla, CA

Investments
Details Hidden

Anaborex, Inc. provides clinical research services for metabolic diseases. The company develops drugs for the treatment of cancer related wasting syndrome. It was founded in 2005 by Alan Saven and Jorge Nieva and is located in La Jolla, CA

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jonas Göran Ekblom. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jonas Göran Ekblom's profile does not indicate a business or promotional relationship of any kind between RelSci and Jonas Göran Ekblom.